1. Home
  2. HAE vs UGP Comparison

HAE vs UGP Comparison

Compare HAE & UGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • UGP
  • Stock Information
  • Founded
  • HAE 1971
  • UGP 1937
  • Country
  • HAE United States
  • UGP Brazil
  • Employees
  • HAE N/A
  • UGP N/A
  • Industry
  • HAE Medical/Dental Instruments
  • UGP Oil/Gas Transmission
  • Sector
  • HAE Health Care
  • UGP Utilities
  • Exchange
  • HAE Nasdaq
  • UGP Nasdaq
  • Market Cap
  • HAE 3.3B
  • UGP 3.2B
  • IPO Year
  • HAE 1991
  • UGP 1999
  • Fundamental
  • Price
  • HAE $71.13
  • UGP $3.12
  • Analyst Decision
  • HAE Strong Buy
  • UGP Buy
  • Analyst Count
  • HAE 9
  • UGP 3
  • Target Price
  • HAE $99.78
  • UGP $4.10
  • AVG Volume (30 Days)
  • HAE 505.1K
  • UGP 2.1M
  • Earning Date
  • HAE 08-07-2025
  • UGP 08-07-2025
  • Dividend Yield
  • HAE N/A
  • UGP 3.92%
  • EPS Growth
  • HAE 44.54
  • UGP N/A
  • EPS
  • HAE 3.31
  • UGP 0.35
  • Revenue
  • HAE $1,360,824,000.00
  • UGP $23,795,634,886.00
  • Revenue This Year
  • HAE N/A
  • UGP $4.89
  • Revenue Next Year
  • HAE $7.18
  • UGP $1.95
  • P/E Ratio
  • HAE $21.49
  • UGP $8.60
  • Revenue Growth
  • HAE 3.96
  • UGP 8.37
  • 52 Week Low
  • HAE $55.30
  • UGP $2.53
  • 52 Week High
  • HAE $94.99
  • UGP $4.51
  • Technical
  • Relative Strength Index (RSI)
  • HAE 60.48
  • UGP 55.47
  • Support Level
  • HAE $68.62
  • UGP $2.98
  • Resistance Level
  • HAE $73.78
  • UGP $3.23
  • Average True Range (ATR)
  • HAE 1.53
  • UGP 0.08
  • MACD
  • HAE -0.20
  • UGP 0.02
  • Stochastic Oscillator
  • HAE 60.51
  • UGP 73.81

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About UGP Ultrapar Participacoes S.A.

Ultrapar Participacoes SA engages in the investment of its own capital in services, commercial, and industrial activities, through the subscription or acquisition of shares of other companies. The Company has three business segments: Ultragaz distributes LPG in the segments: bulk, comprising condominiums, trade, services, industries, and agribusiness; and bottled, mainly comprising residential consumers. The Ipiranga engages in the distribution and sale of oil-related products, biofuels, and similar products to service stations that operate under the Ipiranga brand throughout Brazil and to consumers and carrier-reseller-retailer. The Ultracargo operates in specialized liquid bulk storage solutions in the main logistics centers of Brazil.

Share on Social Networks: